| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 2.3K | 1.3% | 21.3% |
| Total Income | 2.3K | 2.2% | 21.3% |
| Expenditure | 2.1K | 4.1% | 23.1% |
| PBT | 191.98 | 41.1% | 4.1% |
| Net Profit | 148.64 | 38.7% | 8.5% |
| OPM | 9.84% | 4.77pp | 1.48pp |
| NPM | 6.45% | 3.84pp | 0.76pp |
| EPS | 1.84 | 38.7% | 8.9% |
Margin miss widens; sequential PAT collapse despite 16% revenue growth
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade C
Guided 13-14% OPM for FY27; Q2 delivered 9.8%, admitting near-term miss. Sequential PAT collapse unexplained.
Cautiously Optimistic
next 1–2 quarters
Neutral
multi-year
Q2 delivered 16% revenue growth but a devastating 34.9% QoQ PAT collapse and 440-bp OPM miss (9.8% vs. 13-14% guided). Management secured 7-8% pricing retroactively but inflation ran 25%, leaving input-cost headwinds unresolved. Margin recovery deferred to Q4 at earliest. The call exposed execution risk: claimed pricing power did not translate to near-term profitability.
₹2268.8 Cr
Revenue · +16.1% YoY₹148.6 Cr
Reported PAT · +11.5% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Standalone Q2 revenue up 18.9%
OVERSTATEDConsolidated delivered Q2 revenue up 16.1% YoY (₹2268.8 Cr)
Operating margins guided at 13-14% for FY27
MISSDelivered OPM 9.8% in Q2, 440 bps below guidance midpoint
Price increases +7-8% and margin improvement coming in Q3/Q4
MISSQ2 PAT down 34.9% QoQ despite price hikes; realized NPM only 6.5%
Decorative +3% pricing expected in Q2
METDecorative pricing not separately broken out; overall pricing realized 7-8%, not 3%
Industrial pricing +3-5%, so far ~5% booked
PartialIndustrial pricing moves ongoing but overall growth hampered by input cost inflation
Earnings quality
What changed since the last call
OPM target execution risk
DowngradeQ1 call: 'margin guidance 13-14% maintained.' Q2 delivered 9.8%; management now says 'hopefully by quarter four' — admission of Q2/Q3 miss.
Sequential profitability trajectory
DowngradeQ1 implied margin expansion; Q2 PAT -34.9% QoQ reveals input-cost and mix headwinds outpaced pricing gains.
Decorative pricing realization
NeutralGuided +3% in Q2; actual retail/service growth 'mid- to high-single-digit' per call, consistent but pricing impact absorbed by inflation.
Industrial growth confirmation
UpgradeStrong growth in auto ancillary, construction equipment, infrastructure despite margin pressure. Robust demand acknowledged.
The Q&A
Moderate. Analysts (Aditya Bhartia, Pratik, Aniruddha Joshi) probed margin miss, competitive intensity, and subsidiary drag (Nerofix, Bangladesh). Management defended 13-14% as full-year target, blamed inflation timing, and promised Q4 recovery. On decorative margin contraction vs. industry, management conceded 'tremendous competition intensity.' No aggressive pushback; Q&A was clarifying, not combative.
Industrial pricing retrospective hikes — Aditya Bhartia, Investec
AnsweredPrice increases retroactive effective April 1; some from June. Range ~7-8% broadly; crude at ~₹92 ($117). Further discussions ongoing on categories linked to crude.
Gross margin erosion despite pricing — Aditya Bhartia, Investec
AnsweredInflation upwards of 25%; price increase ~7-8%. Remaining gap being discussed further; not all segments realize full pass-through immediately.
13-14% EBITDA margin timeline — Aditya Bhartia, Investec
PartialBy quarter four, think we should be definitely trying to touch that number. Settlements keep happening; difficult to predict exact timing. Clock reset October 1 for next round.
Decorative margin vs. industrial — Aditya Bhartia, Investec
DodgedDecorative margin contraction lower than industry; our mix focused approach and not participating in low-end products tells the story.
Decorative volume and value growth — Pratik, HSBC
PartialVolume with current mix correction nearing double-digit value growth. Last three quarters show sequential improvement; pretty good sign.
Competitive intensity in decorative — Pratik, HSBC
AnsweredEvery quarter hoping it'll go away soon, but not happening. Tremendous competition intensity across regions. No specificity to East India.
Industrial competitive intensity and growth — Aniket, ICICI Securities
PartialYes, competition intensity up. Real mix matters; in industrial, real mix drives profitability. Think Q3 should be good as far as growth. Pipeline good in Q3 at least.
Subsidiaries and adhesive business — Aniruddha Joshi, ICICI Securities
AnsweredSri Lanka closed. Nepal doing very well, ~20% growth, healthy profit. Bangladesh problem; trying to recover. Nerofix now part of Kansai; growth double-digit in revenue but serious pricing issue.
Project business pipeline — Aniruddha Joshi, ICICI Securities
PartialAdded ~3,000 dealers; 75-80% machine dealers. Typical 10% network growth annually. Focus on extraction and store growth, not just numerical expansion.
Construction chemical growth — Aniruddha Joshi, ICICI Securities
AnsweredWaterproofing growth upward of 30%. Construction chemical 60-70% on small base but growing fast. Penetration across country increasing monthly.
Guidance
FY27 growth target not formally stated; Q3/Q4 expected to be better
LowH1 growth +14-14.2% standalone/consolidated; management hopes for sequential improvement but no FY27 number given.
FY27 OPM margin target 13-14% (maintained but near-term misses admitted)
MediumQ2 delivered 9.8%; management targeting Q4 for recovery. Assumes pricing pass-through, crude stabilization, and cost discipline.
₹601 Cr capex over 2-2.5 years for auto, powder, industrial capacity
MediumOn track per call. No specific quarterly breakdown; capacity ramp timings not quantified.
Risks the call surfaced
Margin compression and input cost inflation
HighInflation at 25%; pricing realized only 7-8%. QoQ PAT down 34.9% despite price hikes. OPM 9.8% vs. 13-14% guided. Sequentially worsening trend.
Sequential PAT volatility and QoQ collapse
HighQ2 PAT ₹149Cr down 34.9% QoQ despite +16% YoY revenue growth. Indicates mix deterioration, working capital hits, or input-cost spikes not fully disclosed.
Decorative margin contraction and competitive intensity
HighDecorative segment margins lower than industry average due to competitive intensity. Management expects intensity to persist. Mix-heavy strategy (avoiding low-end) limiting volume upside.
Subsidiary and acquisition integration risks
MediumNerofix (adhesives) merged mid-FY27, carrying VAM inventory losses (~₹4-5 Cr PAT hit Q2). Bangladesh subsidiary unprofitable and under review. Sri Lanka shut. Growth in adhesives offset by profitability headwinds.
Capex execution and capacity absorption
Medium₹601 Cr capex over 2-2.5 years for auto, powder, industrial capacity. No specific ramp timeline or capacity absorption assumptions disclosed. Growth expected but not quantified.
Management
Score 6/10. Moderately clear but evasive on margin recovery timeline. MD Pravin Chaudhari acknowledged challenges (inflation, competition, subsidiary drag) but offered 'hopefully Q4' vs. explicit near-term guidance revision. Numbers cited but rationale for misses not fully transparent. Mixed track record. FY27 13-14% margin guidance not on pace (Q2 9.8%). YoY growth solid (+16% revenue, +11% PAT) but QoQ PAT collapse (-34.9%) unexplained in detail. Pricing initiatives underway but lag inflation.
1 · Q3 FY27 (Dec 2026)
Pricing pass-through from September hikes; OPM recovery target
2 · Q4 FY27 (Mar 2027)
Management target to reach 13-14% OPM; full-year guidance reconcile
3 · FY28
Capex completion (auto, powder, industrial capacity); new product revenue ramp
The call exposed execution risk: claimed pricing power did not translate to near-term profitability.